• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激与帕金森病啮齿动物模型中的突触功能障碍。

Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease.

机构信息

Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; IRCCS Mondino Foundation, Pavia, Italy.

出版信息

Neurobiol Dis. 2022 Oct 15;173:105851. doi: 10.1016/j.nbd.2022.105851. Epub 2022 Aug 23.

DOI:10.1016/j.nbd.2022.105851
PMID:36007757
Abstract

Parkinson's disease (PD) is a multifactorial disorder involving a complex interplay between a variety of genetic and environmental factors. In this scenario, mitochondrial impairment and oxidative stress are widely accepted as crucial neuropathogenic mechanisms, as also evidenced by the identification of PD-associated genes that are directly involved in mitochondrial function. The concept of mitochondrial dysfunction is closely linked to that of synaptic dysfunction. Indeed, compelling evidence supports the role of mitochondria in synaptic transmission and plasticity, although many aspects have not yet been fully elucidated. Here, we will provide a brief overview of the most relevant evidence obtained in different neurotoxin-based and genetic rodent models of PD, focusing on mitochondrial impairment and synaptopathy, an early central event preceding overt nigrostriatal neurodegeneration. The identification of early deficits occurring in PD pathogenesis is crucial in view of the development of potential disease-modifying therapeutic strategies.

摘要

帕金森病(PD)是一种涉及多种遗传和环境因素复杂相互作用的多因素疾病。在这种情况下,线粒体损伤和氧化应激被广泛认为是关键的神经发病机制,这也得到了与线粒体功能直接相关的 PD 相关基因的鉴定的证实。线粒体功能障碍的概念与突触功能障碍密切相关。事实上,有确凿的证据支持线粒体在突触传递和可塑性中的作用,尽管许多方面尚未完全阐明。在这里,我们将简要概述在不同的神经毒素和遗传 PD 啮齿动物模型中获得的最相关证据,重点关注线粒体损伤和突触病,这是在明显的黑质纹状体神经退行性变之前发生的早期中枢事件。鉴于潜在的疾病修饰治疗策略的发展,确定在 PD 发病机制中发生的早期缺陷至关重要。

相似文献

1
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease.氧化应激与帕金森病啮齿动物模型中的突触功能障碍。
Neurobiol Dis. 2022 Oct 15;173:105851. doi: 10.1016/j.nbd.2022.105851. Epub 2022 Aug 23.
2
Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.在帕金森病的MitoPark小鼠模型中,多巴胺能神经元的电生理参数呈现出年龄依赖性下降。
J Neurosci. 2016 Apr 6;36(14):4026-37. doi: 10.1523/JNEUROSCI.1395-15.2016.
3
Current perspective of mitochondrial biology in Parkinson's disease.帕金森病中线粒体生物学的当前观点。
Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.
4
Early synaptic dysfunction in Parkinson's disease: Insights from animal models.帕金森病早期突触功能障碍:来自动物模型的见解。
Mov Disord. 2016 Jun;31(6):802-13. doi: 10.1002/mds.26620. Epub 2016 May 19.
5
Insights on the Correlation between Mitochondrial Dysfunction and the Progression of Parkinson's Disease.探讨线粒体功能障碍与帕金森病进展的关系。
Endocr Metab Immune Disord Drug Targets. 2024;24(9):1007-1014. doi: 10.2174/0118715303249690231006114308.
6
Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.胆固醇在帕金森病的MPTP小鼠模型中导致多巴胺能神经元丢失:线粒体功能障碍和氧化应激的参与。
PLoS One. 2017 Feb 7;12(2):e0171285. doi: 10.1371/journal.pone.0171285. eCollection 2017.
7
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.重印本:重新探讨氧化应激和线粒体功能障碍在帕金森病发病机制中的作用——类似于安非他命类药物滥用的影响。
Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.
8
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.线粒体在帕金森病发病机制及治疗中的核心地位。
CNS Neurosci Ther. 2014 Jul;20(7):591-602. doi: 10.1111/cns.12264. Epub 2014 Apr 7.
9
Connecting the dots between mitochondrial dysfunction and Parkinson's disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity.连接线粒体功能障碍与帕金森病之间的关联:聚焦于靶向线粒体的治疗模式以减轻疾病严重程度。
Environ Sci Pollut Res Int. 2021 Jul;28(28):37060-37081. doi: 10.1007/s11356-021-14619-6. Epub 2021 May 29.
10
Oxidative stress and regulated cell death in Parkinson's disease.帕金森病中的氧化应激与细胞程序性死亡。
Ageing Res Rev. 2021 May;67:101263. doi: 10.1016/j.arr.2021.101263. Epub 2021 Feb 1.

引用本文的文献

1
Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism.大麻二酚在利血平诱导的帕金森病进行性模型中的预防性有益作用。
Front Pharmacol. 2025 May 8;16:1539783. doi: 10.3389/fphar.2025.1539783. eCollection 2025.
2
Reduced composite dietary antioxidant index increases the risk of Parkinson's disease and all-cause mortality in Parkinson's disease patients: evidence from the NHANES database.复合膳食抗氧化指数降低会增加帕金森病患者患帕金森病的风险及全因死亡率:来自美国国家健康与营养检查调查(NHANES)数据库的证据。
Front Aging Neurosci. 2025 Apr 17;17:1510654. doi: 10.3389/fnagi.2025.1510654. eCollection 2025.
3
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS.
解读神经退行性变:阿尔茨海默病、帕金森病和肌萎缩侧索硬化症的分子机制与治疗进展综述
Int J Mol Sci. 2024 Nov 24;25(23):12613. doi: 10.3390/ijms252312613.
4
Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies.姜黄素在神经系统疾病中的研究进展:调节氧化应激的作用及临床研究
Front Pharmacol. 2024 Nov 1;15:1496661. doi: 10.3389/fphar.2024.1496661. eCollection 2024.
5
Unraveling the AKT/ERK cascade and its role in Parkinson disease.解析 AKT/ERK 级联及其在帕金森病中的作用。
Arch Toxicol. 2024 Oct;98(10):3169-3190. doi: 10.1007/s00204-024-03829-9. Epub 2024 Aug 13.
6
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review.胰高血糖素样肽-1(GLP-1)受体激动剂治疗头痛和疼痛障碍:系统评价。
J Headache Pain. 2024 Jul 12;25(1):112. doi: 10.1186/s10194-024-01821-3.
7
The Interplay of Mitochondrial Bioenergetics and Dopamine Agonists as an Effective Disease-Modifying Therapy for Parkinson's Disease.线粒体生物能量学与多巴胺激动剂的相互作用作为一种有效的帕金森病疾病修饰治疗策略。
Mol Neurobiol. 2024 Oct;61(10):8086-8103. doi: 10.1007/s12035-024-04078-8. Epub 2024 Mar 11.
8
Can pluripotent/multipotent stem cells reverse Parkinson's disease progression?多能/多潜能干细胞能逆转帕金森病的病情进展吗?
Front Neurosci. 2024 Jan 31;18:1210447. doi: 10.3389/fnins.2024.1210447. eCollection 2024.
9
Multimodal assessment of mitochondrial function in Parkinson's disease.帕金森病中线粒体功能的多模态评估。
Brain. 2024 Jan 4;147(1):267-280. doi: 10.1093/brain/awad364.
10
Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs.线粒体功能障碍在疾病中的多方面作用:从能量工厂到破坏者。
Arch Pharm Res. 2023 Oct;46(9-10):723-743. doi: 10.1007/s12272-023-01465-y. Epub 2023 Sep 26.